ELhabal, Sammar Fathy http://orcid.org/0000-0002-7970-2288
El-Nabarawi, Mohamed A.
Hassanin, Soha Osama
Hassan, Fatma E.
Abbas, Samah S.
Gebril, Sahar M.
Albash, Rofida
Funding for this research was provided by:
The Science, Technology & Innovation Funding Authority
Article History
Received: 13 April 2024
Accepted: 23 July 2024
First Online: 12 August 2024
Declarations
:
: All authors (S.F. ELhabal, M.A. El‑Nabarawi, S. Hassanin, F.E. Hassan, S.S. Abbas, S.M. Gebril, and R. Albash) declare that they have no conflict of interest.
: The animal studies were performed after receiving approval from the Research Ethics Committee-Faculty of Pharmacy, Cairo University (REC-FOPCU) serial number (code: PI 2942), valid from 28/3/2022. Animal models are among the most crucial in vivo models concerning basic parameters like drug efficiency, safety, and toxicological studies, as these pre-clinical data are essential before translating into humans. The use and handling of animals in our study complied with ARRIVE guidelines for animal experiments.
: All the authors approved the participation.
: All the authors approved the publication of the manuscript.